Last updated: April 24, 2026
This report maps the main supplier landscape for ibuprofen and famotidine across API and finished dosage supply channels, focusing on manufacturers that commonly appear in commercial and regulatory supply chains.
What is the supplier universe for ibuprofen?
API suppliers for ibuprofen
Ibuprofen is a high-volume, long-established NSAID with a broad global API supply base. Typical supplier categories include:
- API producers (ibuprofen API via chemical synthesis)
- Contract manufacturers (API or intermediates under commercial agreement)
- Finished-dose manufacturers (tablets/capsules using supplied API)
Key commercial API manufacturers that supply ibuprofen at scale include:
- BASF (historically active in pharma chemical supply chains)
- Hetero Drugs (API manufacturing footprint across multiple small molecules)
- Aurobindo Pharma (API manufacturing and supply for common generics)
- Sun Pharmaceutical Industries (API production and supply)
- Mylan/Viatris (through branded/generic supply networks)
- Siegfried (where applicable via small-molecule services and supply relationships)
- Teva (where applicable via supply networks and approved products)
Finished-dose suppliers for ibuprofen
In finished dosage, ibuprofen is widely available in OTC and prescription tablets/suspensions. Supplier lists typically include:
- Major generic manufacturers (bulk tablet sourcing and internal API sourcing)
- Local/regional OTC license holders
- Contract packers for private label
The supplier universe for finished ibuprofen is usually broader than API because distributors and packers can qualify products with local licensing requirements.
What is the supplier universe for famotidine?
API suppliers for famotidine
Famotidine is also a mature small-molecule H2 blocker with multiple established global API producers. Typical supplier categories mirror ibuprofen:
- Famotidine API producers
- Intermediates and contract API synthesis
- Finished-dose manufacturers
Common commercial API manufacturer presence includes:
- Sun Pharma (API footprint and generic supply)
- Aurobindo Pharma (API manufacturing and supply networks)
- Teva (product supply networks)
- Hetero Drugs (API manufacturing footprint)
- Mylan/Viatris (generic supply networks)
Finished-dose suppliers for famotidine
Famotidine has extensive global generic coverage across:
- Tablets
- Oral formulations
- Hospital supply lots (often sourced through tender/distributor channels)
Finished-dose supply for famotidine typically involves both:
- Global generic manufacturers
- Regional packers under licensing
Which suppliers dominate small-molecule generic API supply for these drugs?
The practical supplier tiers for ibuprofen and famotidine look like this:
Tier 1: Large integrated or high-volume API/generic groups
- Aurobindo Pharma
- Sun Pharma
- Teva
- Hetero Drugs
- Viatris (Mylan)
- BASF (where relevant to chemical/pharma manufacturing chains)
Tier 2: Specialized small-molecule API manufacturers and intermediates
- Suppliers with strength in chemical synthesis capacity and batch supply reliability
Tier 3: Contract manufacturers and distributors
- Firms that manufacture under agreement or supply through regional distribution and licensing
How do pairing ibuprofen and famotidine affect sourcing?
If your “drug” refers to a fixed-dose combination (FDC) product containing both ibuprofen + famotidine, sourcing changes from single-product APIs to combination supply assurance:
- The API suppliers still supply ibuprofen API and famotidine API.
- The formulation and regulatory pathway depend on whether the combination is:
- A marketed FDC with established formulation know-how
- A co-pack (separate products packed together, not chemically combined)
For combination supply, the controlling factors become:
- consistent API grade and spec compliance
- tablet/capsule formulation fit (dose, disintegration, stability)
- GMP manufacturing slots for the final dosage
- packaging labeling and trade dress
What should procurement screen for when selecting suppliers?
Procurement for both ibuprofen and famotidine generally prioritizes:
- GMP status and compliance record (for API and finished dose)
- Pharmacopoeial coverage (USP/EP grade availability)
- Batch traceability and change control
- Supply continuity (multiple sourcing options)
- Regulatory approvals for the target market (product registration vs API-only import)
For FDC procurement, add:
- Formulation IP/licensing readiness
- Stability package alignment with the target regulatory submission
- Analytical method readiness for the exact combination formulation
Supplier mapping table (high-probability global participants)
The table below reflects large and commonly referenced participants in small-molecule API and generic supply networks for these established actives. It is organized by supplier type and typical relevance to sourcing.
| Drug |
Supplier type |
Common supplier participants (global presence) |
| Ibuprofen |
API |
BASF; Hetero Drugs; Aurobindo Pharma; Sun Pharma; Teva |
| Ibuprofen |
Finished dosage |
Major generic manufacturers; regional OTC packers; contract manufacturers |
| Famotidine |
API |
Sun Pharma; Aurobindo Pharma; Hetero Drugs; Teva; Viatris (Mylan) |
| Famotidine |
Finished dosage |
Major generic manufacturers; hospital-tender suppliers; regional packers |
Key Takeaways
- Ibuprofen and famotidine have broad, established supplier ecosystems because they are mature, high-volume generics.
- The dominant sourcing lanes are large API/generic groups (Aurobindo, Sun, Teva, Hetero, Viatris, BASF where relevant) plus regional packers and contract manufacturers for final dosage.
- If the target is an ibuprofen + famotidine combination product, the sourcing decision shifts from “can you supply API” to “can you supply the exact final dosage under GMP with stability and regulatory readiness.”
FAQs
1) Who are the most likely suppliers to approach first for ibuprofen API?
Large global API and generic groups with high-volume small-molecule manufacturing footprints, including Aurobindo Pharma, Sun Pharma, Teva, Hetero Drugs, and BASF where applicable.
2) Who are the most likely suppliers to approach first for famotidine API?
High-volume small-molecule suppliers with established generic and API operations, including Sun Pharma, Aurobindo Pharma, Hetero Drugs, Teva, and Viatris (Mylan).
3) Does sourcing a combination ibuprofen + famotidine product require different suppliers?
You still source two APIs, but the critical decision becomes final dosage manufacturer capability for the exact formulation and regulatory-ready documentation.
4) Can distributors be the “supplier” for finished ibuprofen or famotidine?
Yes. For finished dosage, tender and OTC procurement often routes through distributors and regional license holders, not only the API manufacturer.
5) What procurement requirements most affect approval timelines?
For these actives: GMP compliance, pharmacopoeial grade, analytical method packages, traceability, and stability support for the exact dosage form and market.
References
[1] EMA. European Medicines Agency: Human medicines: Active substances and pharmacovigilance resources. European Medicines Agency.
[2] FDA. Drug and Device Registration and Submissions. U.S. Food and Drug Administration.
[3] USP. USP-NF: General Chapters and monographs for pharmaceutical substances. United States Pharmacopeia.
[4] ECHA. European Chemicals Agency: Substance information for registered chemicals. European Chemicals Agency.
[5] World Health Organization. Good manufacturing practices for pharmaceutical products. World Health Organization.
